Browsing Tag
Foralumab
2 posts
Tiziana Life Sciences’ multiple sclerosis breakthrough faces commercial and regulatory hurdles
Tiziana Life Sciences stock drops 16% despite positive foralumab results. Explore its $3.9M cash balance, funding risks and MS drug outlook.
Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19
Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal…